A clinical predictive model for hearing recovery after middle ear cholesteatoma surgery based on machine learning

基于机器学习的中耳胆脂瘤手术后听力恢复临床预测模型

阅读:1

Abstract

OBJECTIVE: To explore various factors influencing postoperative hearing recovery in patients with middle ear cholesteatoma and to construct and validate a clinical prediction model for postoperative hearing recovery. METHODS: Clinical data from 548 patients diagnosed with middle ear cholesteatoma, gathered between May 2019 and December 2023, were randomly split into a training cohort and a validation cohort in a ratio of 7:3. To enhance feature selection, we utilized univariate logistic regression analysis, multivariate logistic regression analysis, and the Least Absolute Shrinkage and Selection Operator (LASSO) regression model to identify significant variables and develop the prediction model. The model's ability to predict outcomes was assessed using the Receiver Operating Characteristic (ROC) curve, while its clinical relevance was evaluated through calibration curves and clinical decision curves. Ultimately, the study findings were visually illustrated with a nomogram. RESULTS: The findings from both univariate and multivariate logistic regression analyses suggest that several predictive factors are significant. These factors encompass the completeness of the ossicular chain, granulation tissue presence within the ossicular chain, the use of ossicular prostheses, eustachian tube functionality, instances of mixed hearing loss, ear conditions (either dry or wet), diabetes, and hypertension. For the training cohort, the area under the curve (AUC) was calculated to be 0.992 (95% CI 0.84-0.99), with the Hosmer-Lemeshow test yielding X (2) = 10.54 and p = 0.29. In the validation cohort, the AUC was 0.977 (95% CI 0.82-0.98), and the Hosmer-Lemeshow test revealed X (2) = 8.54 and p = 0.42. After implementing strict post-split preprocessing to mitigate overfitting and data leakage risks, the model was re-evaluated. The bootstrap-corrected AUC for the training cohort was 0.980 (95% CI, 0.82-0.99), and the cross-validated, optimism-corrected AUC for the validation cohort was 0.965 (95% CI, 0.80-0.98). A nomogram has been developed to visually forecast postoperative hearing recovery in individuals diagnosed with middle ear cholesteatoma. Additionally, the calibration curve, along with the clinical decision curve, indicates that this predictive model is both stable and trustworthy. CONCLUSION: This nomogram is an effective tool for predicting hearing recovery in patients with middle ear cholesteatoma, providing evidence-based support for clinical practice.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。